Alcohol Dependence Clinical Trial
— AB-CASIOfficial title:
Automated Bilingual Computerized Alcohol Screen and Intervention in Latinos
Verified date | April 2022 |
Source | Yale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To study the efficacy of AB-CASI against standard of care in a randomized controlled trial in the Emergency Department.
Status | Completed |
Enrollment | 840 |
Est. completion date | April 30, 2020 |
Est. primary completion date | April 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - English and Spanish speaking adult - = 18 y/o - Latino patients who present to the Bridgeport Hospital's ED - Drink over the NIAAA low-risk limits. Exclusion Criteria: - Primary language other than English or Spanish - Current enrollment in an alcohol or substance abuse treatment program - Current ED visit for acute psychosis - Condition that precludes interview or AB-CASI use i.e., life threatening injury/illness - In police custody - Inability to provide two contact numbers for follow-up |
Country | Name | City | State |
---|---|---|---|
United States | Bridgeport Hospital | Bridgeport | Connecticut |
Lead Sponsor | Collaborator |
---|---|
Yale University | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
United States,
Vaca FE, Dziura J, Abujarad F, Pantalon MV, Hsiao A, Field CA, D'Onofrio G. Trial study design to test a bilingual digital health tool for alcohol use disorders among Latino emergency department patients. Contemp Clin Trials. 2020 Sep;96:106104. doi: 10.1016/j.cct.2020.106104. Epub 2020 Aug 7. Corrected and republished in: Contemp Clin Trials. 2020 Sep 16;:106128. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | 30 Day Treatment Engagement | Engagement in alcohol treatment program based on Treatment Services Review at 30 day phone follow up | 30 days post enrollment | |
Primary | Self Reported Binge Drinking Episodes | Self reported number of binge drinking episodes over the previous 28 days assessed using the 28 day timeline follow back at 12 months.
This outcome was corrected 3/2020 to accurately reflect the time frame from the original protocol. |
12 months | |
Secondary | Mean Number of Weekly Drinks | Self reported mean number of weekly drinks as measured by a 28 day timeline follow back.
This outcome was corrected 3/2020 to accurately reflect the time frame from the original protocol. It was also moved to the secondary outcome measure section as was the original intent. |
12 months post enrollment | |
Secondary | Alcohol-Related Negative Health Behaviors and Consequences: episodes of impaired drivin | Self reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school) | 12 months post enrollment | |
Secondary | Alcohol-Related Negative Health Behaviors and Consequences: episodes riding with an impaired driver | Self reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school) | 12 months post enrollment | |
Secondary | Alcohol-Related Negative Health Behaviors and Consequences: number of injuries | Self reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school) | 12 months post enrollment | |
Secondary | Alcohol-Related Negative Health Behaviors and Consequences: number of arrests | Self reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school) | 12 months post enrollment | |
Secondary | Alcohol-Related Negative Health Behaviors and Consequences: episodes of tardiness from work/school | Self reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school) | 12 months post enrollment | |
Secondary | Alcohol-Related Negative Health Behaviors and Consequences: days absent from work/school | Self reported alcohol-related negative health behaviors and consequences based on the Brief Event Data survey (includes episodes of impaired driving, riding with an impaired driver, injuries, arrests, tardiness and days absent from work/school) | 12 months post enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |